Countries China
XPOVIO® has received regulatory approvals in 41 countries and regions including the United States, Israel, the United Kingdo...
July 17, 2023 | News
As an important hematopoietic and metabolic immune organ of human body, red blood marrow is known as the systematic "soldier factory". Red blood marrow is ...
July 17, 2023 | News
Based on the preliminary review of the Company's unaudited management accounts for the six months ended June 30, 2023, the total revenue is ex...
July 14, 2023 | News
Kedrion joined forces with BPL in 2022 This is the first ever approval for a BPL product in China The China Albumin market is the world's largest ...
July 13, 2023 | News
26th Jun 2023, the 13th Singapore Guangdong Collaboration Council was held in Singapore. During the event, leaders from both Governments wit...
July 12, 2023 | News
The commissioning ceremony was attended by Belinda Tanoto, Managing Director of RGE China; Wang Minyan, Chairman of the China Cleaning Industry Associ...
July 12, 2023 | News
Under the terms of the agreement, Doer Bio will grant BioNTech a worldwide license to utilize one of Doer Bio's innovative discoveries to research, develop...
July 12, 2023 | News
The multi-center clinical randomized controlled trial on the ''treatment of Chronic Obstructive Pulmonary Disease (''COPD'') by targeted lung denervation a...
July 11, 2023 | News
The manufacturing site is going to produce PENTAX Medical endoscopic solutions for China. A state-of-the-art service center is to enhance customer ex...
July 11, 2023 | News
RemeGen Co., Ltd. ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a fully-integrated commercial-stage biotechnology company, announce...
July 10, 2023 | News
80Bio, Inc. a clinical stage biotechnology company focused on the development of precision oncology medicines, today announced that the U.S. Food and Drug ...
July 10, 2023 | News
To initiate TranStar 301 global Phase III pivotal trial of Osemitamab (TST001) in combination with Nivolumab and chemotherapy for the first-line treatment ...
July 10, 2023 | News
The study is a prospective, self-controlled, multicenter Phase Ⅲ trial aimed at investigating the additional detection rate and safety of Hexvix®&nbs...
July 10, 2023 | News
Since April of last year, GeneQuantum and Aimed Bio have been collaborating on the joint development of a FGFR3-targeting ADC named GQ1011/AMB302. The prog...
July 07, 2023 | News
Most Read
Bio Jobs
News